ESR1 and breast carcinoma: Co-culture of MSCs with breast cancer increased oxidative phosphorylation, intracellular ATP, and cancer cell resistance to standard therapies for estrogen receptor-positive (ER+) breast cancer (Buschhaus et al., 2023).